Spinal muscular atrophy and Farber disease due to ASAH1 variants: A case report

Am J Med Genet A. 2020 Oct;182(10):2369-2371. doi: 10.1002/ajmg.a.61764. Epub 2020 Jul 5.

Abstract

Genetic variations in the ASAH1 gene are associated with a spectrum of disorders ranging from Farber disease (FD) to spinal muscular atrophy with or without progressive myoclonic epilepsy (SMA-PME). FD presents most commonly in infants with subcutaneous joint nodules, progressive arthritis and granulomas of the larynx and epiglottis leading to a hoarse cry. SMA-PME is characterized by childhood onset progressive weakness due to motor neuron disease followed by progressive epilepsy, tremor, and sensorineural hearing loss. We present a case of a 4-year-old boy with phenotypic features of both FD and SMA who was found to have two previously unreported heterozygous variants in the ASAH1 gene.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acid Ceramidase / genetics*
  • Child
  • Child, Preschool
  • Farber Lipogranulomatosis / genetics*
  • Farber Lipogranulomatosis / pathology
  • Genetic Predisposition to Disease*
  • Genetic Variation
  • Humans
  • Infant
  • Male
  • Muscular Atrophy, Spinal / genetics*
  • Muscular Atrophy, Spinal / pathology

Substances

  • ASAH1 protein, human
  • Acid Ceramidase